Cytodyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients With Relapsed/Refractory Microsatellite Stable Colorectal Cancer
Cytodyn宣佈完成與FDA的會議,討論在晚期微衛星穩定性結直腸癌患者中應用Leronlimab的II期研究。
Cytodyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients With Relapsed/Refractory Microsatellite Stable Colorectal Cancer
Cytodyn宣佈完成與FDA的會議,討論在晚期微衛星穩定性結直腸癌患者中應用Leronlimab的II期研究。
譯文內容由第三人軟體翻譯。